Efficacy of vitamin C for the prevention and treatment of upper respiratory tract infection. A meta-analysis in children
- 323 Downloads
Upper respiratory tract infection (URTI) is a common infection in children, generally caused by viral respiratory infection. Vitamin C is currently proposed as prophylaxis for URTI. The purpose of this study was to assess the effectiveness of vitamin C administration in children for the prevention and reduced duration of URTI through a systematic literature review.
Review of the literature conducted between October 2017 and January 2018 in the main medical databases (CENTRAL, Medline and Embase) and by a gray literature approach. The selection criteria were: double-blind randomized controlled trials (RCTs) comparing vitamin C use to placebo in children aged 3 months to 18 years without chronic infection. Efficacy was assessed in terms of incidence, duration and severity of symptoms of URTI. A meta-analysis was conducted where possible.
Eight RCTs, including 3135 children aged 3 months to 18 years, were selected. Quantitative analysis showed no difference between vitamin C administration and placebo (odds ratio = 0.75, 95% CI [0.54–1.03], p = 0.07, I2 = 74%). Vitamin C administration was found to decrease the duration of URTI by 1.6 days (standardized mean differences = −0.30 [−0.53; −0.08], p = 0.009, I2 = 70%). Children under 6 years of age benefit from more effective vitamin C supplementation associated with echinacea. No serious adverse events were reported.
Although no preventive effects were found, vitamin C intake reduced the duration of URTI. Considering the frequency of URTI, the inappropriate prescription of antibiotics, and the safe nature of vitamin C, its supplementation is justified, especially in children under 6 years of age and those who present a high frequency of URTI. There is a sound rationale for further trials with greater statistical power among children of this age.
KeywordsUpper respiratory tract infection Vitamin C Infants Adolescents Systematic review
Upper respiratory tract infection
Randomized controlled trial
Standardized mean difference
The authors thank Mrs. Nathalie Pinol-Domenech, documentarian at Clermont Auvergne University Campus Health Library. We also thank Mr. Constantini for providing clarifications and additional data for this study.
BA, AC and PV conceptualized and designed the study, selected studies and planned the analysis. BA, PV, BP and AC contributed to the development of the selection criteria, the assessment strategy for the risk of bias and the data extraction criteria; BP provided statistical expertise. AC, BA and PV drafted the manuscript and HVR and EM participated in its improvement. All authors read, provided feedback and approved the final manuscript as submitted.
- 3.InVS | BEH n°01 (6 janvier 2009) Observatoire Hivern@le – KhiObs : surveillance épidémiologique des pathologies hivernales de la sphère ORL chez l’enfant en France. Les recours pour asthme dans les services des urgences d’Île-de-France, 2006–2007. Epidémiologie de la cryptosporidiose humaine en France en 2006 et 2007 : données du réseau Cryptosporidies Anofel. http://invs.santepubliquefrance.fr/beh/2009/01/index.htm. Accessed 3 Jan 2018
- 4.Manzella JP, Roberts NJ (1979) Human macrophage and lymphocyte responses to mitogen stimulation after exposure to influenza virus, ascorbic acid, and hyperthermia. J Immunol 123:1940–1944Google Scholar
- 5.Anderson TW (1977) Large scale studies with vitamin C. Acta Vitaminol Enzymol 31:43–50Google Scholar
- 6.Anderson TW, Suranyi G, Beaton GH (1974) The effect on winter illness of large doses of vitamin C. Can Med Assoc J 111:31–36Google Scholar
- 7.Anderson TW, Beaton GH, Corey P, Spero L (1975) Winter illness and vitamin C: the effect of relatively low doses. Can Med Assoc J 112:823–826Google Scholar
- 11.Hemilä H, Chalker E (2013) Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev:CD000980. https://doi.org/10.1002/14651858.CD000980.pub4
- 13.Cochrane handbook for systematic reviews of interventions | Cochrane Training. http://training.cochrane.org/handbook. Accessed 18 Jan 2018
- 18.Cohen HA, Varsano I, Kahan E et al (2004) Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study. Arch Pediatr Adolesc Med 158:217–221. https://doi.org/10.1001/archpedi.158.3.217 CrossRefGoogle Scholar
- 19.Bancalari A, Seguel C, Neira F et al (1984) Prophylactic value of vitamin C in acute respiratory tract infections in schoolchildren. Rev Med Chil 112:871–876Google Scholar
- 23.Miller JZ, Nance WE, Kang K (1978) A co-twin control study of the effects of vitamin C. Prog Clin Biol Res 24(Pt C):151–156Google Scholar
- 25.Ritzel G (1961) Critical evaluation of vitamin C as a prophylactic and therapeutic agent in colds. Helv Med Acta 28:63–68Google Scholar
- 26.Karsch-Völk M, Barrett B, Kiefer D et al (2014) Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev:CD000530. https://doi.org/10.1002/14651858.CD000530.pub3
- 27.Hao Q, Dong BR, Wu T (2015) Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev:CD006895. https://doi.org/10.1002/14651858.CD006895.pub3